First Industrial Realty Trust Sets Q3 2026 Earnings Call for October 22
Logistics real estate operator First Industrial Realty Trust confirms its Q3 2026 earnings call for October 22, 2026, as the company prepares…
Logistics real estate operator First Industrial Realty Trust confirms its Q3 2026 earnings call for October 22, 2026, as the company prepares…
Therap Services reinforces its compliance leadership by hosting a virtual seminar dedicated to addressing fraud and waste in critical community-based healthcare programs.
JLL Income Property Trust bolsters its $6.9 billion portfolio with a $68.5 million financing deal for an Indianapolis industrial asset, signaling continued…
Jellyfish expands its engineering intelligence platform with new AI-focused features, enabling organizations to better track AI skill adoption and optimize software development…
Harris | Oakmark enters the ETF market with the launch of OAKL, an actively managed fund focused on identifying undervalued U.S. equities…
Gildan Activewear (NYSE: GIL) is under scrutiny as Rosen Law Firm investigates potential securities claims stemming from allegations of misleading corporate disclosures.
Michelle Garza, Director of Strategic Accounts at Anderson & Vreeland, earns top industry honors as the International Metal Decorating & Packaging Association…
Lightbeam Health Solutions leverages AI-driven population health tools to lower operational costs, reduce patient readmissions, and enhance HCC recapture accuracy for healthcare…
Mews reports that 89% of travelers support a hybrid model of AI and human-led hospitality, highlighting a clear preference for behind-the-scenes automation…
Draper Laboratory lands a $7.3 million ARPA-H contract to spearhead Phase 1 of the BioStabilization Systems program, marking a significant win for…
Spring Labs launches SpringGRC, an AI compliance platform underpinned by Winnow’s proprietary legal database, targeting enhanced regulatory efficiency for financial firms.
New lawsuits target Johnson & Johnson and Eli Lilly, alleging that antipsychotic medications Risperdal, Invega, and Zyprexa carry undisclosed breast cancer risks,…